Cowen Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,000
Closed -$716K 262
2016
Q4
$716K Sell
10,000
-65,000
-87% -$4.83M 0.03% 168
2016
Q3
$5.93M Buy
75,000
+50,000
+200% +$4.06M 0.35% 41
2016
Q2
$2.08M Sell
25,000
-35,000
-58% -$3.11M 0.13% 93
2016
Q1
$5.51M Buy
60,000
+55,000
+1,100% +$4.96M 0.21% 80
2015
Q4
$506K Hold
5,000
0.04% 190
2015
Q3
$491K Buy
+5,000
New +$555K 0.03% 175
2014
Q4
Sell
-5,000
Closed -$532K 256
2014
Q3
$532K Buy
+5,000
New +$490K 0.05% 183

Other funds holding GILD

Cowen Inc's GILD Position: Q4 2016 in Review

Cowen Inc sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 10,000 shares — an estimated $743K sold.

Cowen Inc first reported a position in GILD in Q1 2014 and held it in 11 quarters. The position peaked at $4.29M in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Cowen Inc reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Cowen Inc sold 10,000 Gilead Sciences shares in Q4 2016, an estimated $743K.
  • Cowen Inc first reported a position in Gilead Sciences in Q1 2014 and held it in 11 quarters.
  • Cowen Inc's Gilead Sciences position peaked at $4.29M in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.